IMBBY (IMBBY) Stock Price & Analysis
IMBBY (IMBBY) rose 0.24% to USD 37.03 as of June 10, 2026 at 01:02 UTC, according to Nexqual real-time market data.
IMBBY last closed at USD 36.94; the session ranged USD 36.75–37.1 on volume of 33,361 shares. Market capitalization is $28.50B, with a 52-week range of USD 35.9–45.6 (OQX). Source: Nexqual, June 10, 2026 at 01:02 UTC.
Key Statistics (as of June 10, 2026 at 01:02 UTC)
| Price | USD 37.03 |
|---|---|
| Change | ▲ 0.24% (up) |
| Previous Close | USD 36.94 |
| Open | USD 37.06 |
| Day Range | USD 36.75 – 37.1 |
| 52-Week Range | USD 35.9 – 45.6 |
| Volume | 33,361 shares |
| Market Cap | $28.50B |
| Exchange | OQX |
Technical Analysis (IMBBY)
Nexqual's technical model rates IMBBY "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 01:02 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 47.76 (neutral) |
| vs SMA50 | Below (USD 38.41) |
| MACD | -0.51 (negative) |
Analyst Ratings (IMBBY)
Wall Street analysts rate IMBBY "Buy" based on 2 analysts, with a mean price target of USD 44 (range USD 43–45), per Nexqual as of June 10, 2026 at 01:02 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 44 |
| High Target | USD 45 |
| Low Target | USD 43 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (IMBBY)
Source: Nexqual, June 10, 2026 at 01:02 UTC.
Financials & Fundamentals (IMBBY)
| Total Revenue | $19.41B |
|---|---|
| Revenue Growth (YoY) | +4.90% |
| Gross Margin | +36.26% |
| Operating Margin | +16.03% |
| Profit Margin | +8.96% |
| ROE | +37.15% |
| Debt / Equity | 243.8 |
| Current Ratio | 0.7 |
| Total Cash | $497.00M |
| Total Debt | $11.23B |
| Free Cash Flow | $2.50B |
Source: Nexqual, June 10, 2026 at 01:02 UTC.
Financial Health Score (IMBBY)
Nexqual rates IMBBY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 01:02 UTC.
| Growth | Mixed — Revenue +1.9% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 16% |
| Balance Sheet | Critical — $497M cash vs $11.2B debt |
| Cash Flow | Strong — FCF $2.50B, 25% margin |
| Efficiency | Strong — ROE 37%, ROA 7.8% |
Ownership (IMBBY)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +0.92% |
| Shares Outstanding | 769.70M |
| Float | 751.49M |
Source: Nexqual, June 10, 2026 at 01:02 UTC.
Leadership (IMBBY)
IMBBY is led by Lukas Jean-Baptiste Paravicini (age 61), CEO & Director, per Nexqual as of June 10, 2026 at 01:02 UTC.
| CEO & Director | Lukas Jean-Baptiste Paravicini (age 61) |
|---|---|
| CFO & Director | Murray McGowan |
| Investor Relations Director | Peter Durman |
| Director of Corporate Communications | Alex Parsons |
| President of Europe Region | Ales Struminsky |
Major Backers & Investors (IMBBY)
Notable institutional backers of IMBBY include Dodge & Cox Funds-Dodge & Cox Balanced Fund, according to Nexqual as of June 10, 2026 at 01:02 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Dodge & Cox Funds-Dodge & Cox Balanced Fund | 0.38% |
Source: Nexqual, June 10, 2026 at 01:02 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JAPAY | Japan Tobacco | USD 18.92 | ▲ 2.49% |
| BTI | British American Tobacco Indus | USD 59.95 | ▲ 0.39% |
| IMBBF | Imperial Brands PLC | USD 36.7 | ▼ 3.29% |
| DANOY | Danone | USD 15.01 | ▲ 1.21% |
| UVV | Universal Corporation | USD 53.01 | ▼ 1.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:02 UTC. This page is informational and not investment advice.